Marksans Pharma to acquire Netherlands-based QliniQ B.V.
Acquisition provides direct access to the Dutch healthcare market, enhancing Marksans’ sales, distribution and market-access capabilities across regulated European markets
Acquisition provides direct access to the Dutch healthcare market, enhancing Marksans’ sales, distribution and market-access capabilities across regulated European markets
Subscribe To Our Newsletter & Stay Updated